The effect of mitomycin C was tested on Epstein-Barr virus (EBV) antigen and virus DNA synthesis in producer and non-producer cell lines. We found that producer, but not non-producer cell lines, are inducible for early antigen and virus capsid antigen synthesis. Although host DNA synthesis is effectively inhibited by over 99 % in the presence of mitomycin C, virus DNA synthesis in the producer lines is unaffected and induced in parallel with the virus antigens.
INTRODUCTION
Epstein-Barr virus (EBV) DNA is carried continuously in established human lymphoblastoid cell lines (zur Hausen & Schulte-Holthausen, 1970; Klein, 1975) . The expression of virus-associated antigens varies between such lines. In all of them the nuclear antigen EBNA (Reedman & Klein, 1973 ) is the only one consistently detectable, while in others the following antigens may appear spontaneously in a fraction of the cells: MA (membrane antigen), EA (early antigen) and VCA (virus capsid antigen) (Klein et al., 1966; Henle et al., 1970; Henle & Henle, 1966) . Those lines only expressing EBNA have been termed non-producers. EBNA and MA are compatible with cell growth and survival, but the appearance of EA usually signals the entry of a cell into the lytic virus cycle. In the majority of non-producer lines the EBV genome is present as multiple virus DNA equivalents which persist in both a free circular form and as sequences integrated within the host cell genome Andersson & Lindahl, 1976) . Some non-producers appear to have only integrated virus DNA (Andersson & Lindahl, 1976) . In the producers, a number of cells replicate virus DNA which (i) precludes the determination of the number of latent virus DNA equivalents/cell on average and (ii) complicates the characterization of the latent virus genomes. The progress of the virus cycle can be summarized as follows: EBNA-~ MA/EA --, virus DNA synthesis--, VCA virus particles (Ernberg, 1975) . Since a difference exists between producers and nonproducers and since the spontaneous expression of virus antigens and virus DNA synthesis is limited to a fraction of the cells in the producer population at any one time, there must exist mechanisms to restrict the virus cycle. Metabolic inhibitors have been used in an attempt to elucidate at what level these controls exist. For example, a number of metabolic inhibitors have been shown to induce cells to enter the productive EBV cycle. Iododeoxyuridine (IdUrd), bromodeoxyuridine (BrdUrd) and cycloheximide (CH) all have the capacity to induce this virus cycle (Gerber, 1972; Hampar et al., 1972a Hampar et al., , 1976 . In a number of other DNA virus-host cell systems mitomycin C (MMC) has also been shown to induce a virus lytic cycle (Rakusanova et al., 1976; Fogel, 1972; Kaplan et al., 1975) . We have tested the capacity of this drug to induce the expression of EBV antigens in both EBV producer and non-producer cell lines. We find that (i) only producer cell lines are inducible for EA and VCA following MMC treatment and (ii) although host DNA synthesis is effectively inhibited Nilsson & Sundstr6m, 1974 ~-+/--, 1251 antibody detection . $ ALL, Acute lymphocytic leukaemia.
to over 99 % in the presence of MMC, virus DNA synthesis in the producer lines continues and is induced in parallel with the virus antigens.
METHODS
Cell lines. Cells used in this study are given in Table I . Lines were propagated in 5 % CO 2 at 37 °C with high humidity. Medium supply was RPMI 1640 plus 10% foetal calf serum (FCS), 100 #g/ml streptomycin and 100 iu/ml penicillin. Medium was changed every 3 days and cells seeded to an initial density of 2 × 105 to 4 × 105/ml. Living and dead cell counts were estimated with trypan blue exclusion.
Assay for EBV-associated antigens. An amount of 5 × 105 cells was taken from the culture, living and dead cell numbers were determined, and the cells were suspended in hypotonic buffer containing 0.8 mM-MgCI/, 1 mM-CaC12, 30 mM-glycerol, pH 7, for 30 to 60 s. A cell smear was allowed to air-dry on to a glass microscope slide and was subsequently fixed in acetone:methanol (2: 1) for 5 min at -20 ° C. After drying, cells were incubated with fluorescein-conjugated IgG of human sera containing the antiviral antibodies (FITC-IgG).
The sera from which such FITC-IgG was prepared were either EA+VCA+ or EA--VCA+ as determined by a variety of serum specificity tests as described before (Klein & Dombos, 1973) . EB V DATA and complementary RNA (cRNA) preparation. Pure EBV DNA was prepared from the supernatants of P3HR-1 cultures as described by Adams (1975) . The cRNA was synthesized in vitro using all four ribonucleotide triphosphates labelled with tritium (15 to 20 Ci/mmol) or CTP labelled with 3zPO 4 (15 Ci/mmol) (both from The Radiochemical Centre, Amersham). The method of synthesis and purification of cRNA has already been described in detail Moat & Klein, 1978) . The final specific activities of the cRNAs were estimated to be 2 x 107 ct/min//~g (all) and 1.4 × 108 ct/min//~g (32PO4). The cRNA was kept at --20 °C in amounts of 0.1 × SSC (SSC = 0.15 M-NaC1, 0.015 M-sodium citrate, pH 7-2). Nucleic acid hybridization. The details of filter hybridization using 32pO 4 EBV cRNA have been described before 
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to 10 ~g DNA per millipore filter (pore size: 0.45 /am, pre-soaked in 2 x SSC) at a concentration of 30 ng/ml in 6 x SSC/formamide (FA) for 4 days at 50 °C. Control filters inchded 10/~g Mieroeoeeus lysodeikticus DNA. The cRNA-DNA hybrids were treated with 30 #g/ml pancreatic RNase (pre-boiled in 2% sodium acetate pH 5) for 30 rain at room temperature and thereafter washed according to the batch method of Birnstiel et al. (1968) . Radioactivity was determined by toluene-based scintillation counting and was adjusted for a2p decay. The amount of DNA remaining on filters following hybridization was determined according to Burton (1956) and radioactivity normalized to 10/~g DNA. DNA preparation. Cellular DNA was prepared according to the procedure outlined by Lindahl et al. (1976) .
In situ hybridization. The details of the procedure used have been described in detail by . Hybridization was carried out with 3 ng/#l cRNA (all), hybridization time 16 h, temperature 50 °C and incubation mixture of 6 x SSC/50% FA. The cRNA-DNA hybrids were RNase-treated (30/~g/ml), washed and the preparation coated with K2 emulsion. Autoradiography was carried out, slides exposed for 5 days and development carried out with subsequent cell staining, all as described previously .
CsCl density-gradient centrifugation. DNA (50 #g) in 0.1 x SSC together with Microeoccus lysodeikticus DNA (1.731 g/ml) were centrifuged for 60 h at 33 000 rev/min at 4 °C in a Beckman L65-B ultracentrifuge. Six drop fractions were collected and aliquots taken for aH-thymidine counting. Hybridization with a2po4-1abelled cRNA was performed with DNA-loaded Millipore filters as described above and with all the numbered filters in the same hybridization vial to avoid variation. Thymidine incorporation was monitored by liquid scintillation counting in Aquasol.
3H-thymidine incorporation. Cells were labelled with 1 /~Ci/ml 3H-thymidine (sp. act. 5 Ci/mmol, The Radiochemical Centre, Amersham).
RESULTS

Effect of MMC on EB V antigen expression in EB V producer cell lines
The P3HR-1 cell line (Table 1) is a spontaneous producer. In a fraction of the cells, both EA and VCA are expressed spontaneously and a fraction of cells are positive for replicating EBV DNA by in situ hybridization. In preliminary studies we used P3HR-1. Fig. 1 shows the effect of adding different concentrations of MMC to P3HR-1 cell cultures. At MMC concentrations of 50 and 500 ng/ml both EA and VCA are induced in a higher percentage of the cells than obtained without MMC. Antigen induction was clear by day 3. In contrast, DNA synthesis was markedly inhibited at those MMC concentrations which induced the expression of EA and VCA in the P3HR-1 culture (Fig. 2 ). Fig. 3 shows the effect of MMC treatment (1000 ng/ml) on another producer line, Daudi. As can be seen the absolute number of antigen-positive cells increased after treatment. Doses higher than 2000 ng/ml MMC resulted in cell death and no antigen induction. Three other producer cell lines were tested and the results are summarized in Table 2 . In all cases MMC induced both EA and VCA in a percentage of the cells.
Effect of MMC on EB V non-producer cell lines
Both IdUrd and BrdUrd induce EA in a variety of EBV non-producer cell lines (Klein & Dombos, 1973) . The effect of low doses (500 ng/ml) of MMC on a variety of non-producers is shown in Table 3 . Two non-producers, which actually express a low level of EA Epstein-Barr virus cycle induced by mitomycin C 12 (4) 7 (2) 6 (1) 3 (0.2) 0.5 (0.1) --I-
* Average % value of induction is given; numbers in parentheses indicate the average spontaneous level of antigen production.
I" --, No induction detectable.
lines tested responded with no induction of EA or VCA. At higher doses of MMC, the drug's effect was toxic.
Effect of MMC on virus DNA synthesis
The fact that both EA and VCA are induced following MMC treatment of the producer lines is particularly intriguing. As a general rule, DNA synthesis inhibitors prevent the expression of VCA: arabinose C (Gergely et al., 1971) , phosphonoacetic acid (Summers & Klein, 1976) , and both IdUrd and BrdUrd (Klein & Dombos, 1973) . To investigate whether the action of MMC is exceptional in this respect we asked whether those VCA-positive cells following MMC induction incorporated 3H-thymidine. Using combined immunofluorescence and autoradiography it can be seen from Fig. 4 that among the VCA-positive cells following MMC induction of the Maku cell line (a producer) a high number also incorporate 3H-thymidine. Some EA+VCA-cells also incorporate 3H-thymidine which would be expected if virus DNA synthesis preceded VCA synthesis. In fact, studies elsewhere combining in situ hybridization and immunofluorescence have shown that in a population of cells, some of which are expressing EA and VCA and synthesizing virus DNA, a large number of EA+VCA--ceils contain replicating virus DNA . From these results it seems that MMC is not totally inhibiting the DNA synthesis found in VCA-positive cells following induction.
Nature of DNA synthesis in VCA-positive cells following MMC treatment
To analyse the nature of the DNA synthesis unaffected by MMC treatment P3HR-1 cells were treated with 500 ng/ml and on day 3 they were analysed in the following way: (i) for EA and VCA; (ii) for replicating virus DNA by in situ hybridization with 3H EBV cRNA; (iii) for the number of EBV genome copies per diploid quantity of host DNA. Parallel aliquots of cell cultures were also labelled with 3H-thymidine during the last 24 h of MMC treatment (day 3) and the cell DNA extracted. Fig. 5 shows the result of the 3H-thymidine labelling after the DNA has been fractionated on a CsC1 density gradient. Compared to the untreated control cultures the MMC-treated P3HR-1 cultures have a 99.5 % inhibition of 3H-thymidine uptake on day 3. There is also a slight shoulder to the heavy (CG-rich) region of the gradient, the density of which corresponds to about 1.718 g/ml which is the density of EBV DNA (Jehn et al., 1972) . Fractions of this gradient were hybridized with 321)O 4 EBV cRNA. Fig. 5 also shows that the DNA fractions which hybridize correspond to those fractions possessing the buoyant density of EBV DNA. In comparison to the untreated cultures there is approx, a two-to threefold increase in hybridization with 32po 4 EBV cRNA.
The results of the antigen testing are summarized in Table 4 . There was approx, a twofold increase in the number of EA cells and a 10-fold increase in VCA+ ceils following MMC treatment. Following conventional nucleic acid hybridization to estimate the average EBV genome number before and after induction, there was approx, a twofold increase in the number of EBV genome copies (Table 4 ). To determine whether this increase in virus DNA copies reflected an increase per individual cell or whether it was due to replicating virus DNA present in a few cells following induction, in situ hybridization was performed with 3H EBV cRNA. As Table 4 also shows, the number of cells possessing replicating virus DNA as detected by in situ increased twofold in the induced cultures compared to the untreated controls. The comparable increase in the number of EA+ cells, VCA+ cells and virus DNA replication-positive cells following in situ hybridization strongly suggests that it is in VCA-positive cells that virus DNA synthesis is taking place. Moreover, both the increase in the number of virus DNA copies and the detectable peak of 3H-thymidine incorporation in the CsC1 gradient following MMC treatment indicate that virus DNA synthesis can take place in the presence of MMC.
Although both EA and VCA are not induced in non-producer cell lines we tested the effect of MMC on the replication of the virus DNA copies present in Raft which is a commonly used EBV non-producer cell line and which possesses about 50 EBV genomes on average (Nonoyama & Pagano, 1971 ). As Table 4 shows there was no appreciable effect on the average EBV genome number.
DISCUSSION
The effect of MMC as an inducer of the virus cycle in a variety of DNA virus-host cell systems has been documented before. Both SV40 and polyoma DNA-containing transformed cell lines are susceptible to this drug which frequently induces a complete virus cycle in these cases (Morris et al., 1977; Kaplan et al., 1975; Neer et al., 1977) . The mechanism of induction is obscure. However, such previously published data with MMC induction in the SV40 and polyoma systems indicate that only these cell lines already spontaneously synthesizing late virus antigens and replicating virus DNA respond to MMC by induction of I. ERNBERG AND M. H. MOAR antigens and virus DNA synthesis in a much higher number of cells than would otherwise normally do so. Although MMC has previously been reported to be incapable of inducing the EBV cycle (Gerber, 1972) the present results demonstrate that it does in those EBV DNA-containing cell lines classified as producers, analogous to SV40 and polyoma. Most of the envisaged mechanisms of MMC induction focus on the fact that it is an alkylating agent which induces crosslinks in DNA (Szybalski & Iyer, 1964) which can subsequently be removed by cellular repair enzymes (Cole, 1973) . This has led to the conviction that it induces the expression of virus antigens by excising the virus genome from its integrated state (Rakusanova et al., 1976) . However, since in the EBV system a variety of non-producer cell lines also contain multiple virus DNA genomes in the form of free circular DNA molecules ) and yet are non-inducible by MMC, the 'permissiveness' of the host cell is also likely to be important. Indeed, the action of MMC as a virus cycle inducer has been alternatively postulated to be influenced by cellular mechanisms in the main (Morris et al., 1977) . The present results are interesting from three main points of view. First, they demonstrate that a difference exists between the induction capacity, at least as mediated by MMC, of EBV producers and non-producers. Such a division on the basis of results obtained with other virus cycle inducers such as IdUrd and BrdUrd has not been as clear cut as this and suggests that spontaneous antigen expression and virus DNA synthesis is influenced by similar mechanisms operating during MMC induction. Second, the virus DNA synthesis encountered during MMC induction must be refractory to MMC itself. In contrast, both host cell DNA synthesis and the virus DNA replication encountered in non-producers is sensitive to MMC. This also suggests that a difference exists between replicative virus DNA synthesis on the one hand and duplication of the 'latent' multiple virus DNA copies on the other. One possibility is that the first mechanism involves the formation of replicative intermediates, the structures of which preclude the crosslinking effect of MMC. In this regard we have also recently demonstrated that the virus DNA synthesis following superinfection with P3HR-l-derived EBV of EBV DNA-containing lines is insensitive to the action of MMC (Moar & Klein, 1980) . Hampar et al. (1972 b) have previously demonstrated the resistance of EBV DNA replication to hydroxyurea, an effect which might be related to our finding with mitomycin C, although the two drugs are known to act differently on DNA synthesis. Finally, and as a consequence of the insensitivity of virus DNA synthesis of MMC, the discriminatory effects of MMC on host and virus DNA synthesis might be used as a tool to study the separate effects of virus DNA synthesis and host cell DNA synthesis during, for example, EBV primary transformation. This work was supported by grants from the Swedish Cancer Society, Gustav V Jubilee Foundation and in part by NIH contract N01 CP 33316, within the Virus Cancer Program of the National Institutes of Health. I.E. was the recipient of a fellowship in Cancer Immunology from the New York Cancer Research Institute and M.H.M. was the recipient of a fellowship from the European Molecular Biology organization.
